211
Views
7
CrossRef citations to date
0
Altmetric
Research Article

PEG-PCL modification and intestinal sustained-release of solid lipid nanoparticles for improving oral bioavailability of 2-methoxyestradiol

, , , , &
Pages 207-214 | Received 03 Jun 2018, Accepted 25 Sep 2018, Published online: 20 Dec 2018

References

  • Aji Alex, M.R., et al., 2011. Lopinavir loaded solid lipid Nanoparticles (SLN) for intestinal lymphatic targeting. European journal of pharmaceutical sciences, 42 (1–2), 11–18.
  • Cao, Y. H., 2014. The study of 2-methoxyestradiol phospholipid complex. Unpublished thesis. Zhengzhou University.
  • Dingli, D., et al., 2002. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clinical cancer research, 8, 3948–3954.
  • Feng, R.L., et al., 2017. Glycyrrhetinic acid-modified PEG-PCL copolymeric micelles for the delivery of curcumin. Reactive Functional Polymers, 111, 30–37.
  • Feng, S.S., et al., 2009. Poly(lactide)-vitamin E derivative/Montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials, 30, 3297–3306.
  • Guo, X.H., et al., 2009. An investigation on intestinal absorption of a new anticancer drug, 2-methoxyestradiol. Pharmazia, 64, 748–751.
  • Guo, X.H., et al., 2011. Investigation of a new injectable thermosensitive hydrogel loading solid lipid nanoparticles. Pharmazie, 66 (12), 948–952.
  • Guo, X.H., et al., 2012. Preparation and cytotoxicity of 2-methoxyestradiol loaded solid lipid nanoparticles. Anticancer Drug, 23, 185–190.
  • Guo, X.H., et al., 2014. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol. Journal of drug targeting , 22 (5), 421–427.
  • Guo, X.H., et al., 2017. High oral bioavailability of 2-methoxyestradiol in PEG-PLGA micelles-microspheres for cancer therapy. European journal of pharmaceutics and biopharmaceutics, 117, 116–122.
  • He, C.B., et al., 2012. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. Biomaterials, 33 (33), 8569–8578.
  • Hou, L., et al., 2012. Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all- trans -retinoid acid conjugate ternary nanoparticulate drug delivery system. Biomaterials, 33 (21), 5431–5440.
  • Ireson, C.R., et al., 2004. Pharmacokinetics and efficacy of 2- methoxyestradiol and 2-methoxyestradiol-bis-sulphamate in vivo in rodents. British journal of cancer, 90, 932–937.
  • James, J., et al., 2007. Phase I safety, phamacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer. Investigational new drugs, 25, 41–48.
  • Ma, Y.M., et al., 2015. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery. European journal of pharmaceutics and biopharmaceutics, 94, 393–403.
  • Madan, J., et al., 2013. Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells. Nanomedicine, 9, 492–503.
  • Mehnert, W. and Mader, K., 2001. Solid lipid nanoparticles: production, characterization and Applications. Advanced drug delivery reviews, 47, 165–196.
  • Muller, R.H., Radtke, M., and Wissing, S.A., 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced drug delivery reviews, 54, 131–155.
  • Rajkumar, S.V., et al., 2007. Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma. Clinical cancer research, 13, 6162–6167.
  • Ramalingam, P. and Ko, Y.T., 2015. Oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations. Pharmaceutical research, 32, 389–402.
  • Ramalingam, P. and Ko, Y.T., 2016. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Colloids and surfaces. B, Biointerfaces, 139, 52–61.
  • Samad, M.B., et al., 2017. PEG modification of Amorfrutin B from Amorpha fructicosa increases gastric absorption, circulation half-life and glucose uptake by T3T-L1 adipocytes. Biomedicine and pharmacotherapy, 5, 513–519.
  • Shaikh, J., et al., 2009. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European journal of pharmaceutical sciences, 37, 223–230.
  • Shi, L.L., et al., 2016. Positively charged surface-modified solid lipid nanoparticles promote the intestinal transport of docetaxel through multifunctional mechanisms in Rats. Molecular pharmaceutics, 13, 2667–2676.
  • Sidor, C., Amato, R.D., and Miller, K.D., 2005. The potential and suitability of 2-methoxyestradiol in cancer therapy. Clinical cancer research, 11, 6094–6095.
  • Sweeney, C., et al., 2005. A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetic, pharmacodynamic, and efficacy of oral 3- methoxyestradiol capsules in hormone-refractory prostate cancer. Clinical cancer research, 11, 6625–6633.
  • Torchilin, V.P., et al., 1994. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim Biophys Acta, 1195 (1), 181–184.
  • Thanou, M., et al., 2001. Mono-N-carboxymethyl chitosan (MCC), apolyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. Journal of pharmaceutical sciences, 90, 38–46.
  • Venishetty, V.K., et al., 2012. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids and surfaces. B, Biointerfaces, 95, 1–9.
  • Venkateswarlu, V. and Manjunath, K., 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release, 95, 627–638.
  • Wang, T.R., et al., 2016. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin. Colloids and surfaces. B, Biointerfaces, 148, 1–11.
  • Wang, Y.J., et al., 2014. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel. Biomaterials, 35, 7654–7665.
  • Xing, Y.B., et al., 2014. In vitro and in vivo investigation of a novel two-phase delivery system of 2-methoxyestradiol liposomes hydrogel. Journal of Liposome Research, 24 (1), 10–16.
  • Yuan, H., et al., 2013. Improved Transport and Absorption through Gastrointestinal Tract by PEGylated solid lipid nanoparticles. Molecular Pharmaceutics, 10 (5), 1865–1873.
  • Zhou, Q., et al., 2016. Improving the antitumor efficacy of doxorubicin -loaded PEG-PCL copolymer micelles by down-regulating hedgehog pathway. Nanomedecine, 12, 471–471.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.